相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins
Miao Hu et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Liver X Receptor α and Farnesoid X Receptor Are Major Transcriptional Regulators of OATP1B1
Henriette E. Meyer Zu Schwabedissen et al.
HEPATOLOGY (2010)
Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers
Gopal Krishna et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Comprehensive In Vitro Analysis of Voriconazole Inhibition of Eight Cytochrome P450 (CYP) Enzymes: Major Effect on CYPs 2B6, 2C9, 2C19, and 3A
Seongwook Jeong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Effects of Oral Posaconazole on the Pharmacokinetic Properties of Oral and Intravenous Midazolam: A Phase I, Randomized, Open-Label, Crossover Study in Healthy Volunteers
Gopal Krishna et al.
CLINICAL THERAPEUTICS (2009)
Drug-Drug Interactions of Triazole Antifungal Agents in Multimorbid Patients and Implications for Patient Care
Yasmine Nivoix et al.
CURRENT DRUG METABOLISM (2009)
Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors
Christopher Rowan et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Rhabdomyolysis induced by simvastatin-fluconazole combination
Ribhi Hazin et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION (2008)
Clinical reasoning: Rhabdomyolysis after combined treatment with simvastatin and fluconazole
O. Findling et al.
NEUROLOGY (2008)
Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo
I. E. Templeton et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
Oliver A. Cornely et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
Andrew J. Ullmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A sensitive liquid chromatography and mass spectrometry method for the determination of posaconazole in human plasma
Jim X. Shen et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2007)
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2007)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions
II Raad et al.
CLINICAL INFECTIOUS DISEASES (2006)
Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam
TI Saari et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Induction of phase I, II and III drug metabolism/transport by xenobiotics
CJ Xu et al.
ARCHIVES OF PHARMACAL RESEARCH (2005)
Rhabdomyolysis in a patient receiving atorvastatin and fluconazole
J Kahri et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study
D Wexler et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Role of itraconazole metabolites in CYP3A4 inhibition
N Isoherranen et al.
DRUG METABOLISM AND DISPOSITION (2004)
Disposition of posaconazole following single-dose oral administration in healthy subjects
P Krieter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Safety of statins - Focus on clinical pharmacokinetics and drug interactions
S Bellosta et al.
CIRCULATION (2004)
Simvastatin-fluconazole causing rhabdomyolysis
A Shaukat et al.
ANNALS OF PHARMACOTHERAPY (2003)
Pulmonary fungal infection - Emphasis on microbiological spectra, patient outcome, and prognostic factors
KY Chen et al.
CHEST (2001)
Inhibition of in vitro metabolism of simvastatin by itraconazole in humans and prediction of in vivo drug-drug interactions
M Ishigam et al.
PHARMACEUTICAL RESEARCH (2001)
Effects of the antifungal agents on oxidative drug metabolism - Clinical relevance
K Venkatakrishnan et al.
CLINICAL PHARMACOKINETICS (2000)
分享论文
